Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 3/20 | 0.42 |
| ▸ | PGR | P06401 | 2/20 | 0.40 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.34 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.34 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.34 |
| ▸ | ACP1 | P24666 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
| ▸ | SQOR | Q9Y6N5 | 3/20 | 0.33 |
| ▸ | PIM1 | P11309 | 1/20 | 0.33 |
| ▸ | KDM4A | O75164 | 1/20 | 0.33 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.33 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.32 |
| ▸ | MYC | P01106 | 1/20 | 0.32 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.32 |
| ▸ | FABP1 | P07148 | 1/20 | 0.32 |
| ▸ | AR | P10275 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13084048 | 1.00 | PDK2 (0.42) | PDK2PGRABCB1ABCG2HRH4 | |
| SCHEMBL13083991 | 0.99 | PDK2 (0.44) | PDK2PGRABCB1ABCG2HRH4 | |
| SCHEMBL13083962 | 0.99 | PDK2 (0.44) | PDK2PGRABCB1ABCG2HRH4 | |
| SCHEMBL13642974 | 0.97 | PDK2 (0.43) | PDK2PGRABCB1ABCG2HRH4 | |
| SCHEMBL13084065 | 0.96 | PDK2 (0.45) | PDK2PGRABCB1ABCG2HRH4 | |
| SCHEMBL13642977 | 0.91 | PDK2 (0.47) | PDK2PGRMAOB | |
| SCHEMBL13644493 | 0.91 | PDK2 (0.47) | PDK2PGRMAOB | |
| SCHEMBL13642833 | 0.91 | PDK2 (0.47) | PDK2PGRMAOB | |
| SCHEMBL13644497 | 0.89 | ALOX5AP (0.37) | PDK2PIM1GRM2 | |
| SCHEMBL13642832 | 0.89 | ALOX5AP (0.37) | PDK2PIM1GRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8796917-B2 | Compound for an organic optoelectronic device, organic light emitting diode including the same, and display including the organic light emitting diode | CHEIL INDUSTRIES, INC (KR) | 2014-08-05 | — | — | US | disclosed |
| US-8796917-B2 | Compound for an organic optoelectronic device, organic light emitting diode including the same, and display including the organic light emitting diode | CHEIL INDUSTRIES, INC (KR) | 2014-08-05 | — | — | US | disclosed |
| US-20120280613-A1 | COMPOUND FOR AN ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE | CHEIL INDUSTRIES, INC. (KR) | 2012-11-08 | — | — | US | disclosed |
| US-20120280613-A1 | COMPOUND FOR AN ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE | CHEIL INDUSTRIES, INC. (KR) | 2012-11-08 | — | — | US | disclosed |
| EP-2508585-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING ORGANIC LIGHT EMITTING DIODE | Cheil Industries Inc. (KR) | 2012-10-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120280613-A1 | COMPOUND FOR AN ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE | OR51E2, AOX1, OR10J3 | PDK2 1551/4885PGR 3489/4885ABCB1 905/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.